Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of 213.30 billion. The enterprise value is 238.71 billion.
Market Cap | 213.30B |
Enterprise Value | 238.71B |
Important Dates
The last earnings date was Tuesday, April 29, 2025.
Earnings Date | Apr 29, 2025 |
Ex-Dividend Date | Mar 11, 2025 |
Share Statistics
Current Share Class | 1.96B |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.90% |
Shares Change (QoQ) | -1.25% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.87B |
Valuation Ratios
The trailing PE ratio is 16.59 and the forward PE ratio is 13.06.
PE Ratio | 16.59 |
Forward PE | 13.06 |
PS Ratio | 4.01 |
PB Ratio | 5.55 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.18, with an EV/FCF ratio of 13.56.
EV / Earnings | 18.56 |
EV / Sales | 4.27 |
EV / EBITDA | 10.18 |
EV / EBIT | 12.82 |
EV / FCF | 13.56 |
Financial Position
The company has a current ratio of 0.79, with a Debt / Equity ratio of 0.81.
Current Ratio | 0.79 |
Quick Ratio | 0.50 |
Debt / Equity | 0.81 |
Debt / EBITDA | 1.40 |
Debt / FCF | 1.78 |
Interest Coverage | 16.83 |
Financial Efficiency
Return on equity (ROE) is 32.89% and return on invested capital (ROIC) is 16.23%.
Return on Equity (ROE) | 32.89% |
Return on Assets (ROA) | 11.42% |
Return on Invested Capital (ROIC) | 16.23% |
Return on Capital Employed (ROCE) | 25.98% |
Revenue Per Employee | 701,369 |
Profits Per Employee | 169,458 |
Employee Count | 75,883 |
Asset Turnover | 0.55 |
Inventory Turnover | 2.24 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.05% in the last 52 weeks. The beta is 0.53, so Novartis AG's price volatility has been lower than the market average.
Beta (5Y) | 0.53 |
52-Week Price Change | +7.05% |
50-Day Moving Average | 109.76 |
200-Day Moving Average | 107.60 |
Relative Strength Index (RSI) | 49.46 |
Average Volume (20 Days) | 21,571 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis AG had revenue of 53.22 billion and earned 12.86 billion in profits. Earnings per share was 6.38.
Revenue | 53.22B |
Gross Profit | 40.28B |
Operating Income | 17.75B |
Pretax Income | 14.92B |
Net Income | 12.86B |
EBITDA | 22.09B |
EBIT | 17.75B |
Earnings Per Share (EPS) | 6.38 |
Balance Sheet
The company has 7.14 billion in cash and 31.27 billion in debt, giving a net cash position of -24.13 billion.
Cash & Cash Equivalents | 7.14B |
Total Debt | 31.27B |
Net Cash | -24.13B |
Net Cash Per Share | n/a |
Equity (Book Value) | 38.45B |
Book Value Per Share | 19.58 |
Working Capital | -6.51B |
Cash Flow
In the last 12 months, operating cash flow was 19.00 billion and capital expenditures -1.39 billion, giving a free cash flow of 17.61 billion.
Operating Cash Flow | 19.00B |
Capital Expenditures | -1.39B |
Free Cash Flow | 17.61B |
FCF Per Share | n/a |
Margins
Gross margin is 75.68%, with operating and profit margins of 33.35% and 24.16%.
Gross Margin | 75.68% |
Operating Margin | 33.35% |
Pretax Margin | 28.03% |
Profit Margin | 24.16% |
EBITDA Margin | 41.50% |
EBIT Margin | 33.35% |
FCF Margin | 33.08% |
Dividends & Yields
This stock pays an annual dividend of 3.97, which amounts to a dividend yield of 3.69%.
Dividend Per Share | 3.97 |
Dividend Yield | 3.69% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 60.27% |
Buyback Yield | 2.90% |
Shareholder Yield | 6.60% |
Earnings Yield | 6.03% |
FCF Yield | 8.25% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Novartis AG has an Altman Z-Score of 3.71.
Altman Z-Score | 3.71 |
Piotroski F-Score | n/a |